Hudson Bay Capital Management
CTSO icon

Hudson Bay Capital Management’s Cytosorbents Corp CTSO Stock Holding History

Hudson Bay Capital Management’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-68,000
Closed -$542K – 614
2020
Q3 		$542K Hold
68,000
– – 0.01% 465
2020
Q2 		$673K Buy
68,000
+18,000
+36% +$165K 0.01% 398
2020
Q1 		$387K Buy
+50,000
New +$252K 0.01% 383

Other funds holding CTSO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Hudson Bay Capital Management's CTSO Position: Q4 2020 in Review

Hudson Bay Capital Management sold out of Cytosorbents Corp (CTSO) in Q4 2020, closing a stake of 68,000 shares — an estimated $542K sold.

Hudson Bay Capital Management first reported a position in CTSO in Q1 2020 and held it in 3 quarters. The position peaked at $673K in Q2 2020. 94 funds tracked by Wall St. Rank hold CTSO as of Q4 2020.

  • Hudson Bay Capital Management reported no remaining Cytosorbents Corp position as of Q4 2020 after selling out during the quarter.
  • Hudson Bay Capital Management sold 68,000 Cytosorbents Corp shares in Q4 2020, an estimated $542K.
  • Hudson Bay Capital Management first reported a position in Cytosorbents Corp in Q1 2020 and held it in 3 quarters.
  • Hudson Bay Capital Management's Cytosorbents Corp position peaked at $673K in Q2 2020.
  • 94 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q4 2020.

Based on Hudson Bay Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.